Net sales expected to grow mid- to high-single digit and core operating income expected to grow high single to low double-digit.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- NVS Earnings: Entresto Drugmaker Novartis Tops Estimates as Patent Expiry Looms
- NVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- GM, Boeing report quarterly results: Morning Buzz
- Drugmakers modestly raise price on drugs at start of year, WSJ reports
- Iovance Biotherapeutics (IOVA) Forecasts Strong Growth Due to Flagship Treatment